The use of peripherally inserted central catheter reduced the incidence of phlebitis in heart failure patients: A randomized trial.

In conclusion, in severe heart failure patients who received intravenous dobutamine, PICC use reduced the incidence of phlebitis when compared to patients with peripheral venous access. Therefore, the PICC use should considered over peripheral venous access for prolonged intravenous therapy in heart failure patients.